Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Oktober 2018 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Announces Multiple Presentations at Society for Neuroscience Annual Meeting including OTO-413 Presentation Selected as "Hot Topic"

SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced multiple...
29. Oktober 2018 07:30 ET | Quelle: Otonomy, Inc.

Otonomy to Report Third Quarter 2018 Financial Results and Provide Corporate Update

Webcast and Conference Call to be Held at 4:30 p.m. EST on November 5, 2018 SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the...
02. Oktober 2018 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Announces OTIVIDEX™ Data Presentation at American Academy of Otolaryngology - Head and Neck Surgery Foundation Annual Meeting

SAN DIEGO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that...
25. September 2018 16:05 ET | Quelle: Otonomy, Inc.

Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference

SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that...
08. August 2018 16:22 ET | Quelle: Otonomy, Inc.

Otonomy Reports Second Quarter 2018 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today reported financial...
06. August 2018 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Announces OTIPRIO® Co-Promotion Agreement with Mission Pharmacal for Acute Otitis Externa Indication

SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced the...
01. August 2018 16:05 ET | Quelle: Otonomy, Inc.

Otonomy to Report Second Quarter 2018 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced it will...
26. Juli 2018 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Initiates Phase 3 Clinical Trial of OTIVIDEX™ in Ménière’s Disease

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced initiation...
09. Mai 2018 16:20 ET | Quelle: Otonomy, Inc.

Otonomy Reports First Quarter 2018 Financial Results and Provides Corporate Update

SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today reported financial...
02. Mai 2018 07:30 ET | Quelle: Otonomy, Inc.

Otonomy to Report First Quarter 2018 Financial Results and Provide Corporate Update

SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced it will...

Vorherige Seite

Nächste Seite